We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CMT icon
2051
Core Molding Technologies
CMT
$207M
$8K ﹤0.01%
2,650
– –
CTMX icon
2052
CytomX Therapeutics
CTMX
$701M
$8K ﹤0.01%
1,076
+185
+21% +$1.25K
CTSO icon
2053
Cytosorbents Corp
CTSO
$23.3M
$8K ﹤0.01%
2,161
– –
EAT icon
2054
Brinker International
EAT
$8.5B
$8K ﹤0.01%
200
-112
-36% -$4.83K
ETD icon
2055
Ethan Allen Interiors
ETD
$606M
$8K ﹤0.01%
437
+202
+86% +$3.76K
EXTR icon
2056
Extreme Networks
EXTR
$3.92B
$8K ﹤0.01%
1,152
+421
+58% +$2.95K
GCO icon
2057
Genesco
GCO
$432M
$8K ﹤0.01%
181
– –
JBSS icon
2058
John B. Sanfilippo & Son
JBSS
$989M
$8K ﹤0.01%
88
+71
+418% +$6.89K
KOP icon
2059
Koppers
KOP
$965M
$8K ﹤0.01%
219
+15
+7% +$527
MHO icon
2060
M/I Homes
MHO
$3.89B
$8K ﹤0.01%
222
+75
+51% +$3.14K
MODV
2061
DELISTED
ModivCare
MODV
$8K ﹤0.01%
150
+55
+58% +$3.36K
MYRG icon
2062
MYR Group
MYRG
$5.31B
$8K ﹤0.01%
275
– –
NBHC icon
2063
National Bank Holdings
NBHC
$1.9B
$8K ﹤0.01%
242
+109
+82% +$3.84K
PAHC icon
2064
Phibro Animal Health
PAHC
$1.48B
$8K ﹤0.01%
333
+119
+56% +$2.76K
PRNT icon
2065
The 3D Printing ETF
PRNT
$59.5M
$8K ﹤0.01%
385
– –
SHOE
2066
Shoe Station Group
SHOE
$431M
$8K ﹤0.01%
466
– –
SMP icon
2067
Standard Motor Products
SMP
$897M
$8K ﹤0.01%
158
+67
+74% +$3.42K
SPTN
2068
DELISTED
SpartanNash
SPTN
$8K ﹤0.01%
619
– –
JOYY
2069
JOYY Inc
JOYY
$3.77B
$8K ﹤0.01%
169
+36
+27% +$2.12K
EQC
2070
DELISTED
Equity Commonwealth
EQC
$8K ﹤0.01%
250
– –
SASR
2071
DELISTED
Sandy Spring Bancorp Inc
SASR
$8K ﹤0.01%
234
– –
SHI
2072
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
$8K ﹤0.01%
278
– –
KRA
2073
DELISTED
Kraton Corporation
KRA
$8K ﹤0.01%
340
+160
+89% +$3.87K
NUAN
2074
DELISTED
Nuance Communications, Inc.
NUAN
$8K ﹤0.01%
475
+317
+201% +$5.26K
FSB
2075
DELISTED
Franklin Financial Network, Inc.
FSB
$8K ﹤0.01%
257
+159
+162% +$5.24K
81 82
83
84 85

Similar funds

SLAM
Swiss Life Asset Management Zurich $20.4B AUM 28.71% 1-Year Est. Return
EWA
EP Wealth Advisors Torrance, California $20.3B AUM
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
P
&Partners Nashville, Tennessee $20.2B AUM 19.79% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $20.1B AUM 30.42% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.